What’s been driving the demand & series of new orders within ImmunoINSIGHTS?
Importance & scope of Master Services Agreements
Applicability of ONC’s technology to latest new therapies
Possible future investments
Expectations fro FY’23 & beyond
Progress at EarlyCDT Lung & strategic options
Future newsflow
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
